Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 46

1.

Transplantation of mesenchymal stem cells in ALS.

Mazzini L, Vercelli A, Ferrero I, Boido M, Cantello R, Fagioli F.

Prog Brain Res. 2012;201:333-59. doi: 10.1016/B978-0-444-59544-7.00016-0. Review.

PMID:
23186722
2.

Stem cells in amyotrophic lateral sclerosis: state of the art.

Mazzini L, Vercelli A, Ferrero I, Mareschi K, Boido M, Servo S, Oggioni GD, Testa L, Monaco F, Fagioli F.

Expert Opin Biol Ther. 2009 Oct;9(10):1245-58. doi: 10.1517/14712590903186956. Review.

PMID:
19663719
3.

Is it too soon for mesenchymal stem cell trials in people with ALS?

Badayan I, Cudkowicz ME.

Amyotroph Lateral Scler. 2008 Dec;9(6):321-2. doi: 10.1080/17482960802425559. Review.

PMID:
18819027
4.

Stem cell transplantation for amyotrophic lateral sclerosis: therapeutic potential and perspectives on clinical translation.

Faravelli I, Riboldi G, Nizzardo M, Simone C, Zanetta C, Bresolin N, Comi GP, Corti S.

Cell Mol Life Sci. 2014 Sep;71(17):3257-68. doi: 10.1007/s00018-014-1613-4. Epub 2014 Apr 4. Review.

PMID:
24699704
5.

The past, present and future of stem cell clinical trials for ALS.

Thomsen GM, Gowing G, Svendsen S, Svendsen CN.

Exp Neurol. 2014 Dec;262 Pt B:127-37. doi: 10.1016/j.expneurol.2014.02.021. Epub 2014 Mar 6. Review.

6.

Mesenchymal Stem Cells in the Treatment of Amyotrophic Lateral Sclerosis.

Hajivalili M, Pourgholi F, Kafil HS, Jadidi-Niaragh F, Yousefi M.

Curr Stem Cell Res Ther. 2016;11(1):41-50. Review.

PMID:
26329483
7.
8.

Neural and glial progenitor transplantation as a neuroprotective strategy for Amyotrophic Lateral Sclerosis (ALS).

Haidet-Phillips AM, Maragakis NJ.

Brain Res. 2015 Dec 2;1628(Pt B):343-50. doi: 10.1016/j.brainres.2015.06.035. Epub 2015 Jul 14. Review.

PMID:
26187754
9.

Advances in stem cell research for Amyotrophic Lateral Sclerosis.

Papadeas ST, Maragakis NJ.

Curr Opin Biotechnol. 2009 Oct;20(5):545-51. doi: 10.1016/j.copbio.2009.09.003. Epub 2009 Oct 12. Review.

PMID:
19819686
10.

Stem cells for ALS: An overview of possible therapeutic approaches.

Czarzasta J, Habich A, Siwek T, Czapliński A, Maksymowicz W, Wojtkiewicz J.

Int J Dev Neurosci. 2017 Apr;57:46-55. doi: 10.1016/j.ijdevneu.2017.01.003. Epub 2017 Jan 11. Review.

PMID:
28088365
11.

Cellular and molecular approaches to motor neuron therapy in amyotrophic lateral sclerosis and spinal muscular atrophy.

O'Connor DM, Boulis NM.

Neurosci Lett. 2012 Oct 11;527(2):78-84. doi: 10.1016/j.neulet.2012.04.079. Epub 2012 May 8. Review.

PMID:
22579818
12.

[Cellular therapy in amyotrophic lateral sclerosis].

Matías-Guiu J, Barcia JA, García-Verdugo JM, Galán L, Vela A, García-Ramos R.

Neurologia. 2008 May;23(4):226-37. Review. Spanish.

PMID:
18307053
13.

Mesenchymal stem cells: potential in treatment of neurodegenerative diseases.

Tanna T, Sachan V.

Curr Stem Cell Res Ther. 2014;9(6):513-21. Review.

PMID:
25248677
14.

[Stem cells therapy in amyotrophic lateral sclerosis treatment. A critical view].

Soler B, Fadic R, von Bernhardi R.

Rev Neurol. 2011 Apr 1;52(7):426-34. Review. Spanish.

15.

Mesenchymal stem cell therapy for the treatment of amyotrophic lateral sclerosis: signals for hope?

Allers C, Jones JA, Lasala GP, Minguell JJ.

Regen Med. 2014;9(5):637-47. doi: 10.2217/rme.14.30. Review.

PMID:
25372079
16.

Targeted stem cell transplantation strategies in ALS.

Lepore AC, Maragakis NJ.

Neurochem Int. 2007 Jun;50(7-8):966-75. Epub 2006 Oct 20. Review.

PMID:
17055612
17.

Stem cells for amyotrophic lateral sclerosis modeling and therapy: myth or fact?

Coatti GC, Beccari MS, Olávio TR, Mitne-Neto M, Okamoto OK, Zatz M.

Cytometry A. 2015 Mar;87(3):197-211. doi: 10.1002/cyto.a.22630. Epub 2015 Feb 2. Review.

18.

Combining growth factor and stem cell therapy for amyotrophic lateral sclerosis.

Suzuki M, Svendsen CN.

Trends Neurosci. 2008 Apr;31(4):192-8. doi: 10.1016/j.tins.2008.01.006. Epub 2008 Mar 10. Review.

PMID:
18329734
19.

Immunomodulatory properties of mesenchymal stem cells and their therapeutic applications.

Yi T, Song SU.

Arch Pharm Res. 2012 Feb;35(2):213-21. doi: 10.1007/s12272-012-0202-z. Epub 2012 Feb 28. Review.

PMID:
22370776
20.

Human mesenchymal stem cells in the treatment of neurological diseases.

Drela K, Siedlecka P, Sarnowska A, Domanska-Janik K.

Acta Neurobiol Exp (Wars). 2013;73(1):38-56. Review.

Supplemental Content

Support Center